Last updated on June 2020

Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole Based on Prior Endocrine Therapy in Patients With PIK3CA Mutation With Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

Find a site near you

Start Over

Novartis Investigative Site

Dresden, Germany
  Connect »